Nipro Renal Soultions USA, Corporation: MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X, 36.83X, 45X))
Read the official notice at FDA (device) →
Get alerts for Nipro Renal Soultions
The text below is copied from the official FDA (device) record. If anything differs, the official notice is correct.
- Company / brand
- Nipro Renal Soultions USA, Corporation
- Product
- MedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X, 36.83X, 45X))
- Reason / hazard
- Hemodialysis concentrates contain high endotoxin levels
- Classification
- Class II
- Status
- Ongoing
- Distribution / sold at
- Worldwide - US Nationwide distribution in the states of FL, GA, IL, MD, MI, NC, NJ, NV, OH, PA, and the countries of Guatemala and Panama.
- Recall initiated
- 2026-08-05
- Code info
- DB+201-2.1: Lot -NDB5E004(exp.4/30/2027) DB+201-25: Lots - NDB5M011(Exp.12/05/2027, NDB4J003(exp.9/25/2026)
- Product quantity
- 2,327 cases
- Voluntary mandated
- Voluntary: Firm initiated
- City
- Lewisberry
- State
- PA
- Country
- United States
- Event id
- 99573
Free daily digest + "My products" watchlist